공시 • May 15
Oddity Tech Ltd. to Report Q1, 2026 Results on Jun 02, 2026 Oddity Tech Ltd. announced that they will report Q1, 2026 results Pre-Market on Jun 02, 2026 공시 • Mar 13
Pomerantz Law Firm Announces Filing of Class Action Against Oddity Tech Ltd. and Certain Officers Pomerantz LLP announced that a class action lawsuit had been filed against Oddity Tech Ltd. and certain officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 26-cv-02046, was on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Oddity securities between February 26, 2025 and February 24, 2026, both dates inclusive, seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials. The Complaint alleged that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) due to an algorithm change by Oddity's largest advertising partner, Oddity's advertisements were being diverted to lower quality auctions at abnormally high costs; (ii) the foregoing significantly increased Oddity's customer acquisition costs, thereby negatively impacting Oddity's business and financial prospects; (iii) accordingly, Defendants overstated the overall strength, stability, and sustainability of Oddity's digital operating model and/or market position; and (iv) as a result, Defendants' public statements were materially false and misleading at all relevant times. The truth began to emerge on February 25, 2026, when Oddity issued a press release announcing its financial results for the Fourth Quarter and full year ended December 31, 2025. Oddity stated that it experienced a dislocation in its account with its largest advertising partner that was believed to be driven by algorithm changes which diverted Oddity to lower quality auctions at abnormally high costs, which resulted in significant increases in new user acquisition costs that were not correlated with the market or Oddity's historical experience. Oddity's Global Chief Financial Officer stated that given the dislocation Oddity was experiencing in acquisition costs, Oddity expected First Quarter 2026 revenue to decline approximately 30% year-over-year, but hoped to see material improvement in the second half of 2026. Oddity planned to issue its financial outlook for Fiscal Year 2026 in the next few months when it had more visibility. On this news, Oddity's Class A ordinary share price fell $14.28 per share, or 49.21%, to close at $14.74 per share on February 25, 2026. 공시 • Mar 12
Oddity Tech Ltd. (NasdaqGM:ODD) announces an Equity Buyback for $200 million worth of its shares. Oddity Tech Ltd. (NasdaqGM:ODD) announces a share repurchase program. Under the program, the company will repurchase up to $200 million worth of its Class A shares. The program will expire on March 31, 2029 or once the allocated funds have been fully deployed, subject to any future modifications by the Board. 공시 • Feb 25
Oddity Tech Ltd. Provides Earnings Guidance for the First Quarter 2026 Oddity Tech Ltd. provided earnings guidance for the first quarter 2026. The company is experiencing in acquisition costs, company expected first quarter 2026 revenue to decline approximately 30% year-over-year, but hope to see material improvement in the second half of 2026. 공시 • Feb 20
Oddity Tech Ltd. to Report Q4, 2025 Results on Feb 25, 2026 Oddity Tech Ltd. announced that they will report Q4, 2025 results Pre-Market on Feb 25, 2026 공시 • Nov 19
ODDITY Tech Ltd Launches METHODIQ, a Telehealth Platform Reimagining Medical Care ODDITY Tech Ltd. announced the launch of METHODIQ, a medical telehealth platform delivering customized, high-efficacy treatments powered by online diagnosis - without needing to go to a doctor's office or get lost in a drug store. METHODIQ reimagines medical care with science, world-class treatments and AI analysis to deliver the highest standards of care - accessible to everyone. The platform begins with dermatology treatments for acne, hyperpigmentation and eczema, with plans to expand into additional medical domains. Backed by four years of investment and product testing, METHODIQ is launching with one of the most advanced and validated dermatological portfolios in the industry based on large scale consumer studies. It features 28 core products and more than 100 personalized treatment plans, engineered with the goal of unrivaled efficacy with fewer side effects and a best-in-class product experience. 공시 • Oct 23
Oddity Tech Ltd. to Report Q3, 2025 Results on Nov 20, 2025 Oddity Tech Ltd. announced that they will report Q3, 2025 results After-Market on Nov 20, 2025 공시 • Oct 01
Oddity Tech Ltd., Annual General Meeting, Nov 13, 2025 Oddity Tech Ltd., Annual General Meeting, Nov 13, 2025. Location: herzog, fox & neeman, 6 yitzhak sadeh st.,6777506., tel aviv-jaffa Israel 공시 • Jul 24
Oddity Tech Ltd. to Report Q2, 2025 Results on Aug 04, 2025 Oddity Tech Ltd. announced that they will report Q2, 2025 results After-Market on Aug 04, 2025